Your browser doesn't support javascript.
loading
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy.
Mitsuyuki, Satoshi; Nishikubo, Masashi; Shimomura, Yoshimitsu; Ohyama, Yukie; Maruoka, Hayato; Nasu, Seiko; Kubo, Tomoyo; Suzuki, Yuta; Okada, Naoki; Nakagawa, Daishi; Kamijo, Kimimori; Yamamoto, Ryusuke; Nagai, Yuya; Hiramoto, Nobuhiro; Yoshioka, Satoshi; Yonetani, Noboru; Hasegawa, Kohei; Kuroda, Hirokazu; Hasuike, Toshikazu; Doi, Asako; Kondo, Tadakazu; Ishikawa, Takayuki.
Afiliación
  • Mitsuyuki S; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ohyama Y; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Maruoka H; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nasu S; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kubo T; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Suzuki Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Okada N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nakagawa D; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kamijo K; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yamamoto R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nagai Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yoshioka S; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yonetani N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hasegawa K; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kuroda H; Department of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hasuike T; Department of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Doi A; Department of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kondo T; Department of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Eur J Haematol ; 111(1): 57-62, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36965014
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón